Sotera Health Co (NASDAQ:SHC)
| Market Cap | 5.10B+11.9% |
| Revenue (ttm) | 1.22B+8.1% |
| Net Income | 163.48M+580.5% |
| EPS | 0.57+580.6% |
| Shares Out | 285.17M |
| PE Ratio | 31.22 |
| Forward PE | 16.64 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,609,459 |
| Open | 18.13 |
| Previous Close | 18.25 |
| Day's Range | 17.87 - 18.69 |
| 52-Week Range | 13.09 - 19.85 |
| Beta | 1.85 |
| Analysts | Buy |
| Price Target | 20.50(+14.53%) |
| Earnings Date | Nov 3, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About SHC
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$SHC stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in SHC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SHC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SHC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
SHC Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Sterigenics | $211.57M | 43.43% |
| Segment income | $165.74M | 34.02% |
| Nelson Labs | $60.66M | 12.45% |
| Nordion | $49.15M | 10.09% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New SHC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SHC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SHC
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $163.22M |
| VBVanguard Morningstar Small-Cap ETF | $117.84M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $67.66M |
| VXFVanguard Extended Market ETF | $58.28M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | $38.57M |
| DFASDimensional - US Small Cap ETF | $36.53M |
Estimated from each fund’s disclosed top holdings × AUM
SHC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SHC’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score